Jefferies Financial Group’s Pacira BioSciences PCRX Stock Holding History

Jefferies Financial Group’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$7.53K	–	1776
2024 Q3	$7.53K	Sell	500 -76,100	-99%	-$1.3M	﹤0.01%	1389
2024 Q2	$2.19M	Buy	76,600 +5,000	+7%	+$142K	0.02%	521
2024 Q1	$2.09M	Hold	71,600	–	–	0.02%	578
2023 Q4	$2.42M	Sell	71,600 -2,800	-4%	-$81.9K	0.02%	638
2023 Q3	$2.28M	Buy	74,400 +52,400	+238%	+$1.89M	0.02%	581
2023 Q2	$882K	Sell	22,000 -18,500	-46%	-$765K	0.01%	969
2023 Q1	$1.65M	Hold	40,500	–	–	0.01%	723
2022 Q4	$1.56M	Buy	+40,500	New	+$1.97M	0.01%	739

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jefferies Financial Group's PCRX Position: Q1 2026 in Review

Jefferies Financial Group increased its Pacira BioSciences (PCRX) stake by 14% in Q1 2026, buying an estimated $538K and bringing the position to 196,292 shares worth $4.44M. The position accounts for 0.03% of the portfolio, ranked #375.

Jefferies Financial Group first reported a position in PCRX in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.45M in Q4 2025. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

Jefferies Financial Group held 196,292 shares of Pacira BioSciences worth $4.44M as of Q1 2026.
Jefferies Financial Group bought 24,200 Pacira BioSciences shares in Q1 2026, an estimated $538K.
Pacira BioSciences made up 0.03% of Jefferies Financial Group's portfolio in Q1 2026, its #375 holding.
Jefferies Financial Group first reported a position in Pacira BioSciences in Q4 2022 and has held it in 14 quarters since.
Jefferies Financial Group's Pacira BioSciences position peaked at $4.45M in Q4 2025.
241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.